ISPOR Reporting Guidelines for Comparative Effectiveness Research (original) (raw)
Guide to Statistics and Methods
Reporting Guidelines
April 7, 2021
JAMA Surg. 2021;156(7):673-674. doi:10.1001/jamasurg.2021.0534
visual abstract icon editorial comment icon author interview icon Interviews multimedia icon Multimedia audio icon
- Guide to Statistics and Methods SQUIRE Reporting Guidelines for Quality Improvement Studies
Rachel R. Kelz, MD, MSCE, MBA; Todd A. Schwartz, DrPH; Elliott R. Haut, MD, PhD
JAMA Surgery - Guide to Statistics and Methods STROBE Reporting Guidelines for Observational Studies
Amir A. Ghaferi, MD, MS; Todd A. Schwartz, DrPH; Timothy M. Pawlik, MD, MPH, PhD
JAMA Surgery - Guide to Statistics and Methods CHEERS Reporting Guidelines for Economic Evaluations
Oluwadamilola M. Fayanju, MD, MA, MPHS; Jason S. Haukoos, MD, MSc; Jennifer F. Tseng, MD, MPH
JAMA Surgery - Guide to Statistics and Methods TRIPOD Reporting Guidelines for Diagnostic and Prognostic Studies
Rachel E. Patzer, PhD, MPH; Amy H. Kaji, MD, PhD; Yuman Fong, MD
JAMA Surgery - Guide to Statistics and Methods PRISMA Reporting Guidelines for Meta-analyses and Systematic Reviews
Shipra Arya, MD, SM; Amy H. Kaji, MD, PhD; Marja A. Boermeester, MD, PhD
JAMA Surgery - Guide to Statistics and Methods AAPOR Reporting Guidelines for Survey Studies
Susan C. Pitt, MD, MPHS; Todd A. Schwartz, DrPH; Danny Chu, MD
JAMA Surgery - Guide to Statistics and Methods MOOSE Reporting Guidelines for Meta-analyses of Observational Studies
Benjamin S. Brooke, MD, PhD; Todd A. Schwartz, DrPH, MS; Timothy M. Pawlik, MD, MPH, PhD
JAMA Surgery - Guide to Statistics and Methods TREND Reporting Guidelines for Nonrandomized/Quasi-Experimental Study Designs
Alex B. Haynes, MD, MPH; Jason S. Haukoos, MD, MSc; Justin B. Dimick, MD, MPH
JAMA Surgery - Guide to Statistics and Methods The CONSORT Framework
Ryan P. Merkow, MD, MS; Amy H. Kaji, MD, PhD; Kamal M. F. Itani, MD
JAMA Surgery - Guide to Statistics and Methods SRQR and COREQ Reporting Guidelines for Qualitative Studies
Lesly A. Dossett, MD, MPH; Amy H. Kaji, MD, PhD; Amalia Cochran, MD
JAMA Surgery
Full Text
Randomized clinical trials (RCTs) are considered the main source of data driving evidence-based practice and the primary method for establishing the efficacy of an intervention. However, for a variety of reasons, the universe of research questions that can be definitively addressed by traditional RCTs is limited.1 At the heart of comparative effectiveness research (CER) is a desire to generate real-world evidence demonstrating the effectiveness (rather than the efficacy) of an intervention using real-world data (obtained outside the often-ideal conditions of a traditional RCT). As value-based reimbursement models are better integrated into the US health care system and patient-centered care is increasingly emphasized, there will be a greater need for high-quality CER studies to inform the most clinically effective and cost-effective treatments and to help identify the right type of treatment for patients being treated in specific clinical contexts.
- Editorial Effective Use of Reporting Guidelines to Improve the Quality of Surgical Research
JAMA Surgery
Full Text